HCA Slashes Profit Outlook as Uninsured Care Costs Surge; Shares Tumble 10%
HCA is trading near its 52-week low of $330 (7.3% above the low).
Summary
HCA cut its full-year EPS guidance to $28.7-$30.5 from $29.1-$31.5, citing rising uncompensated care as ACA subsidies expire. The company also narrowed its revenue forecast to $77B-$79.5B and cut its 2026 outlook amid sliding surgical volumes. Shares fell nearly 10% premarket. This follows a preliminary Q2 revenue beat of $20.23B, but the profit warning overshadows the top-line strength. Same-facility admissions rose 2.5%, yet inpatient and outpatient surgeries declined, signaling a shift toward lower-acuity care. The guidance cut reflects margin pressure from a growing uninsured population, a headwind likely to persist through the year.
At the time of this announcement, HCA was trading at $354.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $86.7B. The 52-week trading range was $330.00 to $556.52. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.